Shop

Rybelsus® 14 mg is an oral, once-daily tablet containing semaglutide, a GLP-1 receptor agonist designed to help adults with type 2 diabetes manage their blood sugar levels more effectively. In addition to improving glycemic control, Rybelsus also supports weight loss by reducing appetite and slowing digestion, making it a valuable option for patients struggling with both elevated blood sugar and excess weight. As the highest strength in the Rybelsus range, the 14 mg dose is typically used for long-term maintenance once tolerance and efficacy are established.  

Packaging Information

• Product Name: Rybelsus®

• Generic Name: Semaglutide Tablets 14 mg

• Strength: 14 mg per tablet

• Quantity: 10 tablets per pack

• Form: Oral tablet (film-coated)

• Packaging Type:

  • Primary: Blister strip

  • Secondary: Printed carton box containing blister(s) and patient information leaflet (PIL)